Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
TGZxpZMuK8EsHQwB
